Owner DAIICHI PHARMACEUTICAL CO., LTD.

Inventors YOSHINO, Toshiharu; UOTO, Kouichi; NAKAMOTO, Yumi; NAITO, Hiroyuki; MOCHIZUKI, Akiyoshi; NAGATA, Tsutomu; KANNO, Hideyuki; HAGINOYA, Noriyasu; YOSHIKAWA, Kenji; NAGAMOCHI, Masatoshi; KOBAYASHI, Syozo; ONO, Makoto; OHTA, Toshiharu; KOMORIYA, Satoshi

Pub. Number AU-A-2002242954

PCT Pub. Number WO2003/000657

Priority 2001-187105 20.06.01 JP; 2001-243046 09.08.01 JP; 2001-311808 09.10.01 JP; 2001-398708 28.12.01 JP

Filing date 20 March 2002

Wipo publication date 8 January 2003

C07D 209/42 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/75 Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 217/26 Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 513/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 513/14 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

C07C 233/56 Carboxylic acid amides

C07C 237/24 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 031/428 - condensed with carbocyclic rings

A61K 031/429 - condensed with heterocyclic ring systems

A61K 031/437

A61K 031/44 - Non-condensed pyridines

A61K 031/4439

A61K 031/444

A61K 031/454

A61K 031/4545

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/472 - Non-condensed isoquinolines, e.g. papaverine

A61K 031/4725

A61K 031/497

A61K 031/501 - not condensed and containing further heterocyclic rings

A61K 031/502 - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 031/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61K 031/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/5377

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

A61P 009/00 Drugs for disorders of the cardiovascular system